Ponatinib in childhood Philadelphia chromosome –positive leukaemias: an international registry of childhood chronic myeloid leukaemia study
Ponatinib is effective in adults with Philadelphia chromosome –positive (Ph+) leukaemias, but scant data are available regarding the use of this tyrosine kinase inhibitor in children.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Fr édéric Millot, Meinolf Suttorp, Anne B. Versluys, Krzysztof Kalwak, Brigitte Nelken, Stephane Ducassou, Yves Bertrand, André Baruchel Tags: Original Research Source Type: research
More News: Cancer | Cancer & Oncology | Childhood Cancer | Children | Chronic Leukemia | Chronic Myeloid Leukaemia | Leukemia | PET Scan | Study